Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes

29 May 2002

Abstract excerpt

Excessive apoptosis is implicated in the pathogenesis of myelodysplastic syndromes (MDS). We assessed by flow cytometry the expression of several members of the Bcl-2 family in bone marrow mononuclear cells (BMMNC) of 168 MDS samples at diagnosis. The proteins studied were Bcl-2, Bcl-xL (anti-apoptotic), Bax, Bad, Bak, and Bcl-xS (pro-apoptotic). The percentage of BMMNC expressing Bcl-2 and Bcl-xL was higher in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Acute Myeloid Leukemia Research
Share to Cell death mechanisms and regulation
Share to RNA Interference and Gene Delivery

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 12111784
DOI: 10.1002/ajh.10108

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromesPMID 12111784Read ↗

‘Low‐risk’ myelodysplastic syndrome is associated with excessive apoptosis and an increased ratio of pro‐ versus anti‐apoptotic bcl‐2‐related proteinsSemantic proximity Read ↗

The Role of BCL-2 and PD-1/PD-L1 Pathway in Pathogenesis of Myelodysplastic SyndromesSemantic proximity Read ↗

Apoptosis and its role in the myelodysplastic syndromes: implications for disease natural history and treatmentSemantic proximity Read ↗

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patientsSemantic proximity Read ↗

Apoptosis, bcl-2 expression and p53 accumulation in myelodysplastic syndrome, myelodysplastic-syndrome-derived acute myelogenous leukemia and de novo acute myelogenous leukemia.Semantic proximity Read ↗

Altered oncoprotein expression and apoptosis in myelodysplastic syndrome marrow cellsSemantic proximity Read ↗

Impact of growth factors in the regulation of apoptosis in low-risk myelodysplastic syndromes.Semantic proximity Read ↗

bcl-2 expression in myelodysplastic syndromes and its correlation with hematological features, p53 mutations and prognosis.Semantic proximity Read ↗

Inhibition of apoptosis by BCL2 prevents leukemic transformation of a murine myelodysplastic syndromeSemantic proximity Read ↗

Apoptosis and antiapoptotic mechanisms in the progression of myelodysplastic syndromeSemantic proximity Read ↗

Apoptosis-Related Gene Expression Profiling in Hematopoietic Cell Fractions of MDS PatientsSemantic proximity Read ↗

Apoptosis in patients with myelodysplastic syndromes: differential involvement of marrow cells in ‘good’ versus ‘poor’ prognosis patients and correlation with apoptosis-related genesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.